About Ceres Pharma
Ceres Pharma is a company based in Merelbeke (Belgium) founded in 2017 by Marc Coucke and Mario Debel was acquired by Naxicap in June 2021.. The company has 31 employees as of December 31, 2022. Ceres Pharma has completed 4 acquisitions, including AMNOL, Aesculapius and Ceumed. Ceres Pharma offers products and services including Prescription Drugs and Food Supplements.
- Headquarter Merelbeke, Belgium
- Employees 31 as on 31 Dec, 2022
- Founders Marc Coucke, Mario Debel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ceres Pharma
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$197.79 K (USD), Grant
Dec 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
31
as on Dec 31, 2022
-
Investments & Acquisitions
AMNOL
& 3 more
-
Acquired by
Naxicap
(Jun 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ceres Pharma
Ceres Pharma offers a comprehensive portfolio of products and services, including Prescription Drugs and Food Supplements. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Development, production, and distribution of prescription drugs for women’s and family health are undertaken by Ceres Pharma
Production and distribution of food supplements and cosmetics for women’s and family health are carried out by Ceres Pharma
Unlock access to complete
Funding Insights of Ceres Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $197,792
-
First Round
First Round
(01 Dec 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Grant - Ceres Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ceres Pharma
Ceres Pharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Naxicap. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in small and medium-sized businesses are managed by Naxicap.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ceres Pharma
Ceres Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include AMNOL, Aesculapius and Ceumed. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Plant-based healthcare supplements are offered via an online platform.
|
2002 | ||||
|
Dermo-cosmetics products are manufactured by AMNOL in Italy.
|
1978 | ||||
|
Pharmaceutical products, food supplements, and cosmetics are developed and sold.
|
1959 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Ceres Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ceres Pharma Comparisons
Competitors of Ceres Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ceres Pharma
When was Ceres Pharma founded?
Ceres Pharma was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Where is Ceres Pharma located?
Ceres Pharma is headquartered in Merelbeke, Belgium. It is registered at Merelbeke, East Flanders, Belgium.
Who is the current CEO of Ceres Pharma?
Mario Debel is the current CEO of Ceres Pharma. They have also founded this company.
How many employees does Ceres Pharma have?
As of Dec 31, 2022, the latest employee count at Ceres Pharma is 31.
What does Ceres Pharma do?
Ceres Pharma was established in 2017 in Merelbeke, Belgium, within the health and wellness sector. A variety of nutritional supplements is produced and distributed, covering categories like calcium support, joint care, fatigue management, sports nutrition, dietary aids, intestinal health, anti-stress formulas, and skin treatments. Distribution occurs through collaborations with retail outlets. The firm was co-founded by Marc Coucke and Mario Debel, who holds the CEO position.
What products or services does Ceres Pharma offer?
Ceres Pharma offers Prescription Drugs and Food Supplements.
How many acquisitions has Ceres Pharma made?
Ceres Pharma has made 4 acquisitions, including AMNOL, Aesculapius, and Ceumed.
Who are Ceres Pharma's investors?
Ceres Pharma has 2 investors. Key investors include European Union, and Naxicap.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.